
Trade Cabinet Secretary Moses Kuria has come under fire from tobacco control lobby groups for allegedly promoting tobacco consumption. Lobbyists, led by the Kenya Tobacco Control Alliance (KETCA), criticized Kuria for meeting with representatives of British American Tobacco (BAT). The lobby groups accused the government official of undermining efforts to control the use of tobacco products. They stated that the meeting violated regulations regarding interactions between public officers and the tobacco industry. Kuria had expressed his support for the tobacco industry on his Twitter account, following a meeting with BAT's managing director and his team. He announced that BAT was planning to open a factory in Kenya for the manufacturing of tobacco-free oral nicotine pouches. The tobacco industry contributes around 1% to the country's GDP, generating over Sh18 billion annually. However, anti-tobacco groups argue that this move will undermine their efforts to discourage tobacco consumption and transition farmers away from tobacco production. David Odhiambo, a representative from one of the lobby groups, expressed concern over the Trade CS's actions and its impact on the efforts made by the World Health Organization and the Kenyan government.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.



